prostanozol

Other names: 17β-hydroxy-5α-androstano[3,2-c]pyrazole, 17β-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5α-androstane, [3,2-c]pyrazole-5alpha-androstan-17beta-ol, 17beta-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5alpha-androstane, 17beta-hydroxy-5alpha-androstano[3,2c]pyrazole, [3,2-c]pyrazole-5α-androstan-17β-ol, 17β-[(Tetrahydro-2H-pyran-2-yl)oxy]-5α-androst-2-eno[3,2- c]pyrazole

Classifications: 6000

Reasons for prohibition: - DEA Controlled Substance List: Schedule III (source) - WADA S1: Anabolic Agents (source)

References:

Reason: Controlled substance: Schedule III

Label terms: []

Searchable name: prostanozol

GUID: 78c33d55-7b98-4291-878e-5f82c98979b5

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1722274024, "_nanoseconds": 731000000}